Showing results (41-50 of 66) with videos related to
Sort By:
Pageof 7
BMC Neurology|January 8, 2009
The Multiple Sclerosis Risk Sharing Scheme Monitoring Study--early results and lessons for the futureMark Pickin, Cindy L Cooper, Timothy Chater, et al.The Lancet. Neurology|April 6, 2015
Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparatorJacqueline Palace, Martin Duddy, Thomas Bregenzer, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 23, 2018
Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing schemeJacqueline Palace, Martin Duddy, Michael Lawton, et al.Archives of Neurology|September 10, 2008
Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patientsAnu Jacob, Brian G Weinshenker, Ivo Violich, et al.JAMA Neurology|July 2, 2016
Time- and Region-Specific Season of Birth Effects in Multiple Sclerosis in the United KingdomPedro María Rodríguez Cruz, Lucy Matthews, Mike Boggild, et al.Brain : a Journal of Neurology|May 12, 2012
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and JapanJoanna Kitley, M Isabel Leite, Ichiro Nakashima, et al.Journal of Neurosurgery|May 1, 2007
Outcome following surgery for temporal lobe epilepsy with hippocampal involvement in preadolescent children: emphasis on mesial temporal sclerosisMatthew D Smyth, David D Limbrick, Jeffrey G Ojemann, et al.Trials|June 21, 2017
Emergency treatment with levetiracetam or phenytoin in status epilepticus in children-the EcLiPSE study: study protocol for a randomised controlled trialMark D Lyttle, Carrol Gamble, Shrouk Messahel, et al.Seizure|April 8, 2014
Variations in inflammation-related genes may be associated with childhood febrile seizure susceptibilityHedley C A Emsley, Richard E Appleton, Catherine L Whitmore, et al.Lancet (London, England)|April 22, 2019
Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trialMark D Lyttle, Naomi E A Rainford, Carrol Gamble, et al.Pageof 7